Cognitive decline in Parkinson’s disease: Impact on quality of life of caregivers
Objective: This study aimed to investigate the impact of cognitive impairment in Parkinson's disease (PD) on the quality of life (QoL) of carers. Background: The…Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?
Objective: To verify if the verbal trail test can replace the written trail test, seeing that individuals with PD show considerable motor abnormalities that can…Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…Life expectancy and dementia – Two sides of the coin in Parkinson’s disease
Objective: Our primary aim was to evaluate whether Parkinson's disease is associated with an increased risk of dementia and death. Background: The prevalence of Parkinson's…Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease
Objective: Seoul instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, cutoff point of…Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia
Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia
Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…Two new cases of a novel ovario-leukodystrophy related to AARS2 mutation from Korea
Objective: Progressive leukoencephalopathy with primary ovarian failure (LKENP; OMIM # 615889) is a novel ovario-leukodystophy caused by compound heterozygote mutations in the AARS2 gene of…Dementia in Parkinson’s disease: Is male gender a risk factor?
Objective: We investigated the relationship between dementia and gender along with other established risk factors, such as age and disease duration. Background: The rates of…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- 36
- Next Page »